File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1081/BIP-200062850
- Scopus: eid_2-s2.0-22044445098
- PMID: 16022171
- WOS: WOS:000236232700011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Self-designing trial combined with classical group sequential monitoring
Title | Self-designing trial combined with classical group sequential monitoring |
---|---|
Authors | |
Keywords | Adaptive design Clinical trial Early termination Group sequential method Interim analysis |
Issue Date | 2005 |
Publisher | Taylor & Francis Inc. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/10543406.asp |
Citation | Journal Of Biopharmaceutical Statistics, 2005, v. 15 n. 4, p. 667-675 How to Cite? |
Abstract | At the interim analyses of a clinical trial, it is appealing to modify the originally planned sample size in order to achieve an adequate power to detect a meaningful treatment effect. We propose a flexible sequential monitoring scheme through combining the self-designing and classical group sequential methods. The maximum sample size does not have to be specified in advance and one efficacy interim analysis is conducted for the purpose of possible early termination after the first block of data is observed. At the interim analysis for efficacy, the usual sufficient test statistic is used and the type I error rate is adjusted to maintain the overall nominal level. At the final analysis, the test is constructed from a weighted average of the blockwise test statistics based on the sequentially collected data. The weight function at each stage is determined by the observed data prior to that stage. The futility stopping rule allows the trial to be terminated when there is no beneficial treatment effect. We conduct simulation studies to evaluate the performance of the proposed design. Copyright © Taylor & Francis, Inc. |
Persistent Identifier | http://hdl.handle.net/10722/146566 |
ISSN | 2023 Impact Factor: 1.2 2023 SCImago Journal Rankings: 0.812 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yin, G | en_HK |
dc.contributor.author | Shen, Y | en_HK |
dc.date.accessioned | 2012-05-02T08:37:03Z | - |
dc.date.available | 2012-05-02T08:37:03Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | Journal Of Biopharmaceutical Statistics, 2005, v. 15 n. 4, p. 667-675 | en_HK |
dc.identifier.issn | 1054-3406 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/146566 | - |
dc.description.abstract | At the interim analyses of a clinical trial, it is appealing to modify the originally planned sample size in order to achieve an adequate power to detect a meaningful treatment effect. We propose a flexible sequential monitoring scheme through combining the self-designing and classical group sequential methods. The maximum sample size does not have to be specified in advance and one efficacy interim analysis is conducted for the purpose of possible early termination after the first block of data is observed. At the interim analysis for efficacy, the usual sufficient test statistic is used and the type I error rate is adjusted to maintain the overall nominal level. At the final analysis, the test is constructed from a weighted average of the blockwise test statistics based on the sequentially collected data. The weight function at each stage is determined by the observed data prior to that stage. The futility stopping rule allows the trial to be terminated when there is no beneficial treatment effect. We conduct simulation studies to evaluate the performance of the proposed design. Copyright © Taylor & Francis, Inc. | en_HK |
dc.language | eng | en_US |
dc.publisher | Taylor & Francis Inc. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/10543406.asp | en_HK |
dc.relation.ispartof | Journal of Biopharmaceutical Statistics | en_HK |
dc.subject | Adaptive design | en_HK |
dc.subject | Clinical trial | en_HK |
dc.subject | Early termination | en_HK |
dc.subject | Group sequential method | en_HK |
dc.subject | Interim analysis | en_HK |
dc.subject.mesh | Algorithms | en_US |
dc.subject.mesh | Clinical Trials As Topic - Statistics & Numerical Data | en_US |
dc.subject.mesh | Data Interpretation, Statistical | en_US |
dc.subject.mesh | Research Design | en_US |
dc.subject.mesh | Sample Size | en_US |
dc.title | Self-designing trial combined with classical group sequential monitoring | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Yin, G: gyin@hku.hk | en_HK |
dc.identifier.authority | Yin, G=rp00831 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1081/BIP-200062850 | en_HK |
dc.identifier.pmid | 16022171 | - |
dc.identifier.scopus | eid_2-s2.0-22044445098 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-22044445098&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 15 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 667 | en_HK |
dc.identifier.epage | 675 | en_HK |
dc.identifier.isi | WOS:000236232700011 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Yin, G=8725807500 | en_HK |
dc.identifier.scopusauthorid | Shen, Y=7404766770 | en_HK |
dc.identifier.issnl | 1054-3406 | - |